In Phase A, participants will get various doses and schedules of oral ABBV-744 tablet to discover safe dosing regimen. More participants is going to be enrolled within the recognized monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section https://valeriusb332oal5.estate-blog.com/profile